| References |
|
|
Adams BD,
Furneaux H and
White BA
(2007)
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ER) and represses ER messenger RNA and protein expression in breast cancer cell lines.
Molecular Endocrinology
21:
1132–1147.
|
|
|
Barrandon C,
Spiluttini B and
Bensaude O
(2008)
Non-coding RNAs regulating the transcriptional machinery.
Biology of the Cell
100:
83–95.
|
|
|
Blenkiron C and
Miska EA
(2007)
miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
Human Molecular Genetics
16(Spec no 1):
R106–R113.
|
|
|
Cai X and
Cullen BR
(2007)
The imprinted H19 noncoding RNA is a primary microRNA precursor.
RNA
13:
313–316.
|
|
|
Calin GA,
Sevignani C,
Dumitru CD et al.
(2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.
Proceedings of the National Academy of Sciences of the USA
101:
2999–3004.
|
|
|
Callis TE and
Wang DZ
(2008)
Taking microRNAs to heart.
Trends in Molecular Medicine
14:
254–260.
|
|
|
Carninci P and
Hayashizaki Y
(2007)
Noncoding RNA transcription beyond annotated genes.
Current Opinion in Genet Development
17:
139–144.
|
|
|
Chen K and
Rajewsky N
(2007)
The evolution of gene regulation by transcription factors and microRNAs.
Nature Reviews. Genetics
8:
93–103.
|
|
|
Chendrimada TP,
Finn KJ,
Ji X et al.
(2007)
MicroRNA silencing through RISC recruitment of eIF6.
Nature
447:
823–828.
|
|
|
Chubb JE,
Bradshaw NJ,
Soares DC,
Porteous DJ and
Millar JK
(2008)
The DISC locus in psychiatric illness.
Molecular Psychiatry
13:
36–64.
|
|
|
Cimmino A,
Calin GA,
Fabbri M et al.
(2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2.
Proceedings of the National Academy of Sciences of the USA
102:
13944–13949.
|
|
|
Dahm R,
Kiebler M and
Macchi P
(2007)
RNA localisation in the nervous system.
Seminars in Cell & Developmental Biology
18:
216–223.
|
|
|
Dieci G,
Fiorino G,
Castelnuovo M,
Teichmann M and
Pagano A
(2007)
The expanding RNA polymerase III transcriptome.
Trends in Genetics
23:
614–622.
|
|
|
Fu X,
Ravindranath L,
Tran N,
Petrovics G and
Srivastava S
(2006)
Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1.
DNA and Cell Biology
25:
135–141.
|
|
|
Hagan JP and
Croce CM
(2007)
MicroRNAs in carcinogenesis.
Cytogenetic and Genome Research
118:
252–259.
|
|
|
Hennessy E and
O'Driscoll L
(2008)
Molecular medicine of microRNAs: structure, function and implications for diabetes.
Expert Reviews in Molecular Medicine
10:
e24.
|
|
|
Hon LS and
Zhang Z
(2007)
The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
Genome Biology
8:
R166.
|
|
|
Hutchinson JN,
Ensminger AW,
Clemson CM et al.
(2007)
A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains.
BMC Genomics
8:
39.
|
|
|
Imamura T,
Yamamoto S,
Ohgane J et al.
(2004)
Non-coding RNA directed DNA demethylation of Sphk1 CpG island.
Biochemical and Biophysical Research Communications
322:
593–600.
|
|
|
Ivanovska I,
Ball AS,
Diaz RL et al.
(2008)
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
Molecular and Cellular Biology
28:
2167–2174.
|
|
|
Ji P,
Diederichs S,
Wang W et al.
(2003)
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early stage non-small cell lung cancer.
Oncogene
22:
8031–8041.
|
|
|
Kaneko S,
Aki I,
Tsuda K et al.
(2006)
Origin and evolution of processed pseudogenes that stabilize functional Makorin1 mRNAs in mice, primates and other mammals.
Genetics
172:
2421–2429.
|
|
|
Kent OA and
Mendell JT
(2006)
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene
25:
6188–6196.
|
|
|
Kiriakidou M,
Tan GS,
Lamprinaki S et al.
(2007)
An mRNA m7G cap binding-like motif within human Ago2 represses translation.
Cell
129:
1141–1151.
|
|
|
Kumar MS,
Lu J,
Mercer KL,
Golub TR and
Jacks T
(2007)
Impaired microRNA processing enhances cellular transformation and tumorigenesis.
Nature Genetics
39:
673–677.
|
|
|
Kuwabara T,
Hsieh J,
Nakashima K,
Taira K and
Gage FH
(2004)
A small modulatory dsRNA specifies the fate of adult neural stem cells.
Cell
116:
779–793.
|
|
|
Lalande M and
Calciano MA
(2007)
Molecular epigenetics of Angelman syndrome.
Cellular and Molecular Life Sciences
64:
947–960.
|
|
|
Leygue E
(2007)
Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer.
Nuclear Receptor Signaling
5:
e006.
|
|
|
Lin R,
Maeda S,
Liu C,
Karin M and
Edgington TS
(2007)
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene
26:
851–858.
|
|
|
Linsley PS,
Schelter J,
Burchard J et al.
(2007)
Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression.
Molecular and Cellular Biology
27:
2240–2252.
|
|
|
Liu J
(2008)
Control of protein synthesis and mRNA degradation by microRNAs.
Current Opinion in Cell Biology
20:
214–221.
|
|
|
Lu J,
Getz G,
Miska EA et al.
(2005)
MicroRNA expression profiles classify human cancers.
Nature
435:
834–838.
|
|
|
Lu Z,
Liu M,
Stribinskis V et al.
(2008)
MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene.
Oncogene
27:
4373–4379.
|
|
|
Mariner PD,
Walters RD,
Espinoza CA et al.
(2008)
Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock.
Molecular Cell
29:
499–509.
|
|
|
Mattes J,
Collison A and
Foster PS
(2008)
Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation.
Current Opinion in Molecular Therapy
10:
150–157.
|
|
|
Mattick JS and
Makunin IV
(2006)
Non-coding RNA.
Human Molecular Genetics
15(Spec No 1):
R17–R29.
|
|
|
Meng F,
Henson R,
Wehbe-Janek H et al.
(2007)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology
133:
647–658.
|
|
|
Peterlin BM and
Price DH
(2006)
Controlling the elongation phase of transcription with P-TEFb.
Molecular Cell
23:
297–305.
|
|
|
Pizzuti A,
Novelli G,
Ratti A et al.
(1999)
Isolation and characterization of a novel transcript embedded within HIRA, a gene deleted in DiGeorge syndrome.
Molecular Genetics and Metabolism
67:
227–235.
|
|
|
Royo H and
Cavaillé J
(2008)
Non-coding RNAs in imprinted gene clusters.
Biology of the Cell
100:
149–166.
|
|
|
Rump P,
Zeegers MP and
van Essen AJ
(2005)
Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis.
American Journal of Medical Genetics Part A
136:
95–104.
|
|
|
Sasaki YT,
Sano M,
Ideue T et al.
(2007)
Identification and characterization of human non-coding RNAs with tissue-specific expression.
Biochemical and Biophysical Research Communications
357:
991–996.
|
|
|
Sonkoly E,
Ståhle M and
Pivarcsi A
(2008)
MicroRNAs: novel regulators in skin inflammation.
Clinical and Experimental Dermatology
33:
312–315.
|
|
|
Sutherland HF,
Wadey R,
McKie JM et al.
(1996)
Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome.
American Journal of Human Genetics
59:
23–31.
|
|
|
Szymanski M,
Barciszewska MZ,
Erdmann VA and
Barciszewski J
(2005)
A new frontier for molecular medicine: noncoding RNAs.
Biochimica et Biophysica Acta
1756:
65–75.
|
|
|
Tsang WP,
Wong TW,
Cheung AH,
Co CN and
Kwok TT
(2007)
Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR.
RNA
13:
890–898.
|
|
|
Vincent JB,
Petek E,
Thevarkunnel S et al.
(2002)
The RAY1/ST7 tumor-suppressor locus on chromosome 7q31 represents a complex multi-transcript system.
Genomics
80:
283–294.
|
|
|
Walter J and
Paulsen M
(2003)
Imprinting and disease.
Seminars in Cell & Developmental Biology
14:
101–110.
|
|
|
Wang H,
Iacoangeli A,
Popp S et al.
(2002)
Dendritic BC1 RNA: functional role in regulation of translation initiation.
Journal of Neuroscience
22:
10232–10241.
|
|
|
Wentzensen N,
Coy JF,
Knaebel HP et al.
(2007)
Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers.
International Journal of Cancer
121:
1417–1423.
|
|
|
Wu J,
Qin Y,
Li B,
He WZ and
Sun ZL
(2008)
Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma.
Genomics
91:
443–450.
|
|
|
Zhu S,
Si ML,
Wu H and
Mo YY
(2007)
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
Journal of Biological Chemistry
282:
14328–14336.
|
| Further Reading |
|
|
Clark SJ
(2007)
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Human Molecular Genetics
16(Spec No 1):
R88–R95.
|
|
|
Costa FF
(2008)
Non-coding RNAs, epigenetics and complexity.
Gene
410:
9–17.
|
|
|
Liu J
(2008)
Control of protein synthesis and mRNA degradation by microRNAs.
Current Opinion in Cell Biology
20:
214–221.
|
|
|
book
Mattick JS
(2003)
"Introns and noncoding RNAs the hidden layer of eukaryotic complexity".
In: Barciszewski J and
Erdmann VA (eds),
Noncoding RNAs: Molecular Biology and Molecular Medicine,
pp. 12–33.
Georgetown, TX: Landes Bioscience.
|
|
|
Papagiannakopoulos T and
Kosik KS
(2008)
MicroRNAs: regulators of oncogenesis and stemness.
BMC Medicine
6:
15.
|
|
|
Stenvang J and
Kauppinen S
(2008)
MicroRNAs as targets for antisense-based therapeutics.
Expert Opinion on Biological Therapy
8:
59–81.
|
